News
Know more about Mycointech reading our news and posts!
Lastest articles
Understanding the Difference: In Vivo vs. In Vitro Commercial Mycorrhizal Inoculum Production—and Why It Matters
As the demand for commercial mycorrhizal inoculum grows, industry forecasts predict the global mycorrhiza market will reach $2 billion within the next decade, with a CAGR of 10-15%. But not all commercial mycorrhizal inocula are created equal. There are two primary...
Mycointech participates as Silver Sponsor at ICOM12 in Manchester
Mycointech is excited to announce our participation as a Silver Sponsor at the 12th International Conference on Mycorrhiza (ICOM12), held from August 4th to 9th in Manchester, UK. This prestigious event brings together leading scientists, researchers, and industry...
MYCOINTECH BECOMES AN INNOVATIVE SME
The Ministry of Science and Innovation of the Government of Spain recognizes MYCOINTECH as an innovative SME, granting it the prestigious innovative SME seal. This badge is awarded with the aim of valuing small and medium-sized companies that are committed to...
Design and development of new microbial preparations for improving agricultural yield in horticultural and fruit crops
The CDTI project (File IDI-20240067), with the title “Design and development of new microbial preparations for improving agricultural yield in horticultural and fruit crops”, aims to develop biofertilizers and biostimulant products with a broad spectrum of action....
Mycointech Brings Customized Mycorrhizal and Biological Products to the Commercial Market
The market for mycorrhizae and other bio-stimulants is exploding. Mycointech, short for Mycorrhizal Industrial Technology, is pioneering the way mycorrhizae, bacteria and other microbes are produced, quantified and used to solve the world’s complex crop production...